Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins.
about
Status of hepatitis C virus vaccination: Recent updateHepatitis C virus: why do we need a vaccine to prevent a curable persistent infection?The Distribution of Hepatitis C Virus Genotypes in Middle Eastern Countries: A Systematic Review and Meta-AnalysisAgent-Based Model Forecasts Aging of the Population of People Who Inject Drugs in Metropolitan Chicago and Changing Prevalence of Hepatitis C InfectionsAssessing the feasibility of hepatitis C virus vaccine trials: results from the Hepatitis C Incidence and Transmission Study-community (HITS-c) vaccine preparedness study.Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses.The Strange, Expanding World of Animal Hepaciviruses.The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.Will there be a vaccine to prevent HCV infection?Vaccine-induced cross-genotype reactive neutralizing antibodies against hepatitis C virus.Effect of route of delivery on heterologous protection against HCV induced by an adenovirus vector carrying HCV structural genes.The role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatments.Mathematical Modeling of Hepatitis C Prevalence Reduction with Antiviral Treatment Scale-Up in Persons Who Inject Drugs in Metropolitan ChicagoVaccination with dendritic cells pulsed with hepatitis C pseudo particles induces specific immune responses in mice.Immunoglobulin with High-Titer In Vitro Cross-Neutralizing Hepatitis C Virus Antibodies Passively Protects Chimpanzees from Homologous, but Not Heterologous, ChallengeHepatitis C Virus E1 and E2 Proteins Used as Separate Immunogens Induce Neutralizing Antibodies with Additive PropertiesComparative Immunogenicity in Rabbits of the Polypeptides Encoded by the 5' Terminus of Hepatitis C Virus RNAAntibodies to an interfering epitope in hepatitis C virus E2 can mask vaccine-induced neutralizing activityEver closer to a prophylactic vaccine for HCV.Therapeutic DNA vaccination using in vivo electroporation followed by standard of care therapy in patients with genotype 1 chronic hepatitis C.The novel replication-defective vaccinia virus (Tiantan strain)-based hepatitis C virus vaccine induces robust immunity in macaquesWill there be a vaccine to protect against the hepatitis C virus?Prospects for prophylactic hepatitis C vaccines based on virus-like particlesProgress towards a hepatitis C virus vaccine.Preclinical evaluation of multi antigenic HCV DNA vaccine for the prevention of Hepatitis C virus infection.Advances in hepatitis C virus vaccines, Part one: Advances in basic knowledge for hepatitis C virus vaccine design.Animal models for the study of hepatitis C virus infection and replication.Virus-like particle-based vaccines against hepatitis C virus infection.Current progress in development of hepatitis C virus vaccines.Hepatitis C virus infection and related liver disease: the quest for the best animal modelImmune mechanisms of vaccine induced protection against chronic hepatitis C virus infection in chimpanzees.Modeling hepatitis C virus transmission among people who inject drugs: Assumptions, limitations and future challenges.Progress in the development of vaccines for hepatitis C virus infection.Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens.T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates.Designing an HCV vaccine: a unique convergence of prevention and therapy?Persistent replication of a hepatitis C virus genotype 1b-based chimeric clone carrying E1, E2 and p6 regions from GB virus B in a New World monkey.Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection.Amino acid residue-specific neutralization and nonneutralization of hepatitis C virus by monoclonal antibodies to the E2 protein.Identification and retrospective validation of T-cell epitopes in the hepatitis C virus genotype 4 proteome: an accelerated approach toward epitope-driven vaccine development.
P2860
Q26774612-75B36D58-C590-45F9-A12C-2A8E958A122BQ26799141-AF432A02-9482-4BAB-8899-40156300B75BQ28076929-7936985D-01D8-4165-836C-A41B1C199F80Q28548643-E8FBD054-5E90-467D-AD5D-B9E629BC43B4Q30208996-E890ADD4-CACC-41E6-8C28-1599F9420056Q33602744-03CF199D-CA48-490B-B4E1-F6354EB5694CQ33924522-E57889CB-1AAE-4839-AD6F-D5E4051E4AC4Q34481429-2A0A6C6D-DC54-48E7-838D-774AEBDCBF8EQ34781537-698EDE42-B18A-4A60-B558-5FC3BD0F33A4Q35465926-943D05FF-8995-4F58-8748-7B84CF7806C1Q35576891-FB95A891-996C-49F3-ACC3-4B072558D4D8Q35750560-AAB87689-3C60-4837-8C04-8E28EAE05813Q35752296-7007D602-71BD-4961-AD2E-A9D0D7936174Q35776114-52FDF3F3-CA64-4289-BF31-4CA459759B63Q35913863-4C613C97-869C-4E0A-A457-A1E2468AD830Q35953659-A11651FB-503B-4FE0-934D-44981986B090Q36280098-C803DE73-66EC-415B-B296-6DC9BF7C0857Q36378193-578E6860-74DC-409B-8D15-098C84D4C19EQ37089122-90BEB260-8061-4871-BB3F-A73F6EB42DD4Q37181381-00F5C020-9836-4F79-85E5-D9E0A046F5E1Q37181386-37CB829A-460B-45AF-BE86-22BD10F6512FQ37389655-E988C2FD-AEA3-4B62-A99A-B6DC84E070CBQ37505405-0D427EB3-1C1F-497D-94AC-40CB76EB94CDQ37584338-2737FB8A-C0E5-4EE0-849B-BFADF5DAA913Q37684017-27B5AC99-377F-4A01-810D-90FC2C34A433Q37948856-0EDD8C15-0D1A-4AA1-827F-90BDCA416A1CQ38021989-800DB574-80E3-425C-B927-819CF3FB97DAQ38081966-8DC5CB8C-BB35-4BFA-941E-A5EB78BA69B1Q38120201-5D2D4336-4AC5-4906-9B14-277A0EF1739BQ38125192-234A315A-62B1-4E8D-9064-596A6F1A310AQ38334024-1BB92F43-6B95-4B67-8EA1-22509A1CAD5EQ38573508-C3B8B6DC-3B5F-4ACF-B2C5-F35DE08EED53Q38635596-0C69CF92-224F-4082-BE4E-B0B838E0EEC6Q38667931-0AEF74C7-9D37-4277-9FA6-5E4BDB2C3AA6Q38758212-66BCFF55-1173-4DD8-9585-181A225EE71FQ39333862-B0A54303-1ABA-4EBD-9526-6D2BD50F308CQ40244787-0479264D-E517-4E90-8F21-7E3B016BB9BEQ40588780-72330687-BDB0-425F-9257-F68414195E5DQ41168118-7B3C9FDA-11C3-4289-95AB-2B165003DF0FQ41648212-F81E7C3C-59F3-4BE9-827F-029B6D49BCD0
P2860
Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Meta-analysis of hepatitis C v ...... tance for structural proteins.
@ast
Meta-analysis of hepatitis C v ...... tance for structural proteins.
@en
Meta-analysis of hepatitis C v ...... tance for structural proteins.
@nl
type
label
Meta-analysis of hepatitis C v ...... tance for structural proteins.
@ast
Meta-analysis of hepatitis C v ...... tance for structural proteins.
@en
Meta-analysis of hepatitis C v ...... tance for structural proteins.
@nl
prefLabel
Meta-analysis of hepatitis C v ...... tance for structural proteins.
@ast
Meta-analysis of hepatitis C v ...... tance for structural proteins.
@en
Meta-analysis of hepatitis C v ...... tance for structural proteins.
@nl
P2093
P2860
P1433
P1476
Meta-analysis of hepatitis C v ...... tance for structural proteins.
@en
P2093
Harel Dahari
Marian E Major
Stephen M Feinstone
P2860
P304
P356
10.1053/J.GASTRO.2010.05.077
P407
P577
2010-06-02T00:00:00Z